DP-NDD

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameDP-NDD
Drug Alias Namemembrane active chelator derivative of BAPTA (D-Pharm)DP-460DP-NDD
ClassificationSmall molecules
Mechanisms of ActionChelating agentsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsCognitive DysfunctionAmyotrophic Lateral SclerosisAlzheimer Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUnivo Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUnivo Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsCognitive DysfunctionAmyotrophic Lateral SclerosisAlzheimer Disease +[5] 

Other Information

ATC CodeN/A
Related LinksN/A